简体中文 | 繁體中文 | English

Press Releases

2019-03-12 10:54 Japan Manganime Factory Changes the Distribution Model of Japanese Manga in the World
2019-03-12 10:48 60 Award-Winning Agents Gear up for Hong Kong’s New MICE Tourism Era in 2019
2019-03-12 10:21 Incredible Concurrent Events At CHINAPLAS 2019
2019-03-12 10:17 Seoul Semiconductor’s Acrich NanoDriver Series Chosen for Sapphire Award at Strategies in Light 2019
2019-03-12 10:07 Nike Deepens Its Commitment to the Next Generation of Female Athletes, Kicking Off with the Upcoming Summer of Football
2019-03-12 10:00 Interactive Brokers Providing Access to Tel Aviv Stock Exchange
2019-03-12 10:00 Ooredoo Group Accelerates 5G Network Transformation with P.I. Works Artificial Intelligence
2019-03-12 10:00 Key Industry Players Converge to Advance CXL, a New High-Speed CPU Interconnect for Breakthrough Data Center Performance
2019-03-12 09:47 Celgene Submits Application to EMA for Ozanimod for the Treatment of Relapsing-Remitting Multiple Sclerosis
2019-03-12 09:30 Purchasing Property in Turkey With Cryptocurrency Now Possible With Antalya Homes
2019-03-11 17:44 Tricor Group Appoints Catharine Wong in Hong Kong as Executive Director and Head of Investor Services
2019-03-11 15:28 Gemalto Expands Cloud HSM On Demand Solutions
2019-03-11 14:23 Spotify Announces Expansion of Strategic Partnership with Samsung
2019-03-11 10:22 South Korea Most Advanced in 5G Leadership, Arthur D. Little Analysis Finds
2019-03-11 10:15 ABB and Formula E celebrate partnership at 50th race in Hong Kong
2019-03-11 10:11 Vedolizumab (Entyvio®) Achieves Superior Rates of Clinical Remission vs. Adalimumab (Humira®) in First Ever Head-to-Head Biologic Clinical Study in Ulcerative Colitis
2019-03-11 10:08 International Child Celebrity, Emiliano Cyrus Aged 10 Appointed as the Republic of Palau's Honorary Goodwill Ambassador for Tourism by President of The Republic of Palau, Tommy Remengesau
2019-03-11 10:06 New ESMO Guidelines Include FOTIVDA®▼(tivozanib) Recommendation for Patients with Advanced Renal Cell Carcinoma
2019-03-11 10:03 Galderma Presented Final Results from Phase 2b Study of Nemolizumab in Patients with Moderate-to-Severe Atopic Dermatitis at the 2019 American Academy of Dermatology Annual Meeting Late-Breaking Session
2019-03-08 20:00 Vitruvias Therapeutics Inc. Launches Shanghai-Based Sinotherapeutics’s Approved Version of Propafenone ER in the U.S.

Business Wire Weibo

Industries

Latest Releases